What is Travere Therapeutics'stock price?
Travere Therapeutics trades on the NASDAQ under the ticker symbol "RTRX." What is Travere Therapeutics' stock price today? One share of RTRX stock can currently be purchased for approximately $25.89. How much money does Travere Therapeutics make?
What are analysts' target prices for Travere Therapeutics' shares?
6 Wall Street analysts have issued 12 month target prices for Travere Therapeutics' shares. Their forecasts range from $19.00 to $45.00. On average, they anticipate Travere Therapeutics' share price to reach $32.67 in the next twelve months. This suggests a possible upside of 44.4% from the stock's current price.
When will Travere Therapeutics report Q4 earnings?
SAN DIEGO, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2021 financial results on Thursday, February 24, 2022 after the close of the U.S. financial markets.
What is the price of rtrx stock?
One share of RTRX stock can currently be purchased for approximately $25.89. How much money does Travere Therapeutics make? Travere Therapeutics has a market capitalization of $1.32 billion and generates $175.34 million in revenue each year.
See more
When will Travere Therapeutics release its earnings?
How much does Travere Therapeutics make?
Travere Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021. View our earnings forecast for Travere Therapeutics.
When is Travere Therapeutics earnings call?
How much money does Travere Therapeutics make? Travere Therapeutics has a market capitalization of $799.89 million and generates $198.32 million in revenue each year. The company earns $-169,430,000.00 in net income (profit) each year or ($3.56) on an earnings per share basis.
What is Travere Therapeutics?
Travere Therapeutics will be holding an earnings conference call on Thursday, July 29th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 404-537-3406 with passcode "9790904".
What time do you trade in the pre market?
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease.
Does market cap include convertible securities?
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment.
